DCF — WILKES-BARRE GENERAL HOSPITAL
Enterprise Value: $-523.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-523.5M
Enterprise Value
$-163.7M
PV of Cash Flows
$-359.8M
PV of Terminal Value
$-579.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $270.0M | $-33.7M | -12.0% | $-45.1M | $-41.0M |
| Year 2 | $278.1M | $-31.9M | -11.0% | $-43.7M | $-36.1M |
| Year 3 | $286.4M | $-30.0M | -10.0% | $-42.1M | $-31.6M |
| Year 4 | $295.0M | $-29.4M | -10.0% | $-41.9M | $-28.6M |
| Year 5 | $303.9M | $-29.5M | -10.0% | $-42.4M | $-26.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-523.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$262.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12970809473384975
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5